Titlebook: Serological Cancer Markers; Stewart Sell Book 1992 Springer Science+Business Media New York 1992 antigen.breast cancer.cancer.carcinoma.ce

使乳化

Sex-Associated Hormones,in tumors (Moore, 1936; McEwen et al., 1975, 1982; Noble, 1977; Trachtenberg and Walsh, 1982). It has been known for many years that prognosis of patients with various malignancies differ between males and females, and some tumors can be alleviated and partially controlled by endocrine therapy (Beat

弯弯曲曲

Tissue Polypeptide Antigen and Specific TPA,ors. Horse antiserum against the protein recognized both soluble form of TPA in human sera and body fluids, and an insoluble form in human tissues. Originally TPA was thought to be a tumor marker and, more recently, a proliferation marker (Björklund, 1980). TPA levels are elevated in the sera of pat

enlist

ALOFT

Glycoamines: Structural-Functional Characterization of a New Class of Human Tumor Markers,terization of glycoamines as a new class of potential humoral tumor markers is of great interest, since the level of the free form of glycoamines is known to be elevated in blood plasma from animals and humans with a wide range of malignant neoplasms and leukoses (Glinsky, 1988a,b, 1989). It is impo

使成波状

,CA 15–3 Assay for the Detection of Episialin,um. Such markers are commonly used for the management of disease in cancer patients. For breast cancer, several assays have been developed based on MAbs against a sialomucin called episialin. These assays appear to be useful tools for monitoring breast cancer, since they show a higher sensitivity th

可行

,Clinical Applications of CA 15–3, putative breast cancer markers, only a few have been found to have sufficient sensitivity and specificity to be useful clinically. Of these, carcinoembryonic antigen (CEA) has been the most commonly used and has been considered the “gold standard.”

HPA533

,CA 19–9, GICA (Gastrointestinal Cancer Antigen), first and basic tumor markers, the discovery of blood group-related carbohydrate structures on glycoproteins and glycolipids as indicators of malignancy has opened a wide array of scientific and clinical work (Lloyd, 1987). This has only become fully assessable by the introduction of hybridoma tech

exhilaration

audiologist

DU-PAN-2, A Clinically Useful Mucin Marker of Differentiation of Pancreatic and Other Ductal Cells se is rarely diagnosed at an early stage. This is the major factor in the poor prognosis of this malignancy. Symptoms, when they occur, are vague and include anorexia, weight loss, abdominal pain, vomiting, nausea, and jaundice. Patients with tumors of the head of the pancreas often have symptoms re

amphibian